NCPA Congressional Pharmacy Fly-In

Hundreds of community pharmacists came to our nation's capital to share their insights on how to address the rising costs of prescription drugs and impediments to patient access to pharmacy services with their members of Congress.

Here's a look at some of the developments that transpired during the 2018 Pharmacy Summit:

  • Community pharmacists visited more than 250 Congressional offices for meetings; the equivalent of more than 600 pharmacist interactions with members of Congress and their staff members.

  • Community pharmacists lobbied to substantially increase the number of congressional cosponsors for The Improving Transparency and Accuracy in Medicare Part D Drug Spending Act (S. 1044/H.R. 1939), The Ensuring Seniors Access to Local Pharmacies Act (S. 1044/H.R. 1939), and The Prescription Drug Price Transparency Act (H.R. 1316).

  • Attendees also pressed Congress to grant pharmacists provider status under Medicare Part B, fix lingering problems with compounding regulations, and offered recommendations for stemming the opioid epidemic.

  • Sen. Shelley Moore Capito (R-W.Va.) and Rep. Doug Collins (R-Ga.), champions of community pharmacy, addressed members at the gathering.

  • Attendees heard from expert panels about recent developments with the Medicare Part D program, such as the Centers for Medicare and Medicaid Service’s release of their Part D final rule.